Summary:
We are seeking adult participants for an investigational Respiratory Syncytial Virus vaccine clinical research study.
The objectives of this study are:
- To evaluate the tolerability of an investigational medication co-administered with a COVID vaccine
- To evaluate the effect of a co-administered COVID vaccine on the immune system response to RSV
- To evaluate the effect of co-administered investigational RSV vaccine on the immune system response to COVID
Qualified Participants Must:
• 50 years of age or older
•
Additional qualification criteria exist
Qualified Participants May Receive:
- Reimbursement available up to $875
- You are provided study-related care and study medicine at no cost (no health insurance required)
- You may help make a difference for yourself and for people like you